|28.37||-0.8400||-2.88%||Vol 166.90K||1Y Perf 237.57%|
|Apr 19th, 2021 11:48 DELAYED|
|- -%||- -|
|Target Price||39.25||Analyst Rating||Moderate Buy 1.75|
|Potential %||38.30||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★+ 53.12|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★+ 49.34|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Market Cap||3.87B||Earnings Rating||—|
|Price Range Ratio 52W %||62.70||Earnings Date||13th May 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||13th May 2021|
|Estimated EPS Next Report||0.12|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||347.31K|
|Avg. Monthly Volume||589.97K|
|Avg. Quarterly Volume||754.36K|
Covetrus Inc. (NASDAQ: CVET) stock closed at 29.21 per share at the end of the most recent trading day (a -1.95% change compared to the prior day closing price) with a volume of 500.57K shares and market capitalization of 3.87B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 5500 people. Covetrus Inc. CEO is Benjamin Wolin.
The one-year performance of Covetrus Inc. stock is 237.57%, while year-to-date (YTD) performance is 1.64%. CVET stock has a five-year performance of %. Its 52-week range is between 7.51 and 40.78, which gives CVET stock a 52-week price range ratio of 62.70%
Covetrus Inc. currently has a PE ratio of -108.50, a price-to-book (PB) ratio of 2.60, a price-to-sale (PS) ratio of 1.20, a price to cashflow ratio of 65.20, a PEG ratio of 2.32, a ROA of -0.73%, a ROC of -0.91% and a ROE of -1.79%. The company’s profit margin is 0.62%, its EBITDA margin is 4.60%, and its revenue ttm is $3.27 Billion , which makes it $24.03 revenue per share.
Of the last four earnings reports from Covetrus Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.12 for the next earnings report. Covetrus Inc.’s next earnings report date is 13th May 2021.
The consensus rating of Wall Street analysts for Covetrus Inc. is Moderate Buy (1.75), with a target price of $39.25, which is +38.30% compared to the current price. The earnings rating for Covetrus Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Covetrus Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Covetrus Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.35, ATR14 : 1.87, CCI20 : -46.16, Chaikin Money Flow : 0.02, MACD : -1.72, Money Flow Index : 46.41, ROC : 2.24, RSI : 39.98, STOCH (14,3) : 37.04, STOCH RSI : 0.73, UO : 46.15, Williams %R : -62.96), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Covetrus Inc. in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.